Related Articles
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy
Pre‑treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer
Effect of levocarnitine administration in patients with chronic liver disease
Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer
Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab‑paclitaxel: A retrospective study